Singapore markets open in 7 minutes

Abrdn Life Sciences Investors (HQL)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
13.47-0.13 (-0.96%)
At close: 03:59PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 371.97M
Enterprise value N/A
Trailing P/E 17.22
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)16.36
Price/book (mrq)0.93
Enterprise value/revenue 15.81
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.72
52-week change 32.95%
S&P500 52-week change 327.84%
52-week high 314.37
52-week low 311.34
50-day moving average 313.44
200-day moving average 313.11

Share statistics

Avg vol (3-month) 384.69k
Avg vol (10-day) 383.3k
Shares outstanding 527.35M
Implied shares outstanding 627.61M
Float 8N/A
% held by insiders 10.01%
% held by institutions 134.38%
Shares short (30 Apr 2024) 458.45k
Short ratio (30 Apr 2024) 40.23
Short % of float (30 Apr 2024) 4N/A
Short % of shares outstanding (30 Apr 2024) 40.21%
Shares short (prior month 28 Mar 2024) 421.32k

Dividends & splits

Forward annual dividend rate 41.33
Forward annual dividend yield 49.78%
Trailing annual dividend rate 31.30
Trailing annual dividend yield 39.56%
5-year average dividend yield 49.13
Payout ratio 4162.03%
Dividend date 331 Dec 2018
Ex-dividend date 421 Feb 2024
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Sept 2022
Most-recent quarter (mrq)31 Mar 2023

Profitability

Profit margin 156.45%
Operating margin (ttm)-48.76%

Management effectiveness

Return on assets (ttm)-0.32%
Return on equity (ttm)1.28%

Income statement

Revenue (ttm)3.51M
Revenue per share (ttm)0.13
Quarterly revenue growth (yoy)34.40%
Gross profit (ttm)N/A
EBITDA N/A
Net income avi to common (ttm)5.5M
Diluted EPS (ttm)0.78
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)822
Total cash per share (mrq)0
Total debt (mrq)9.33M
Total debt/equity (mrq)2.21%
Current ratio (mrq)0.27
Book value per share (mrq)16.12

Cash flow statement

Operating cash flow (ttm)N/A
Levered free cash flow (ttm)N/A